January 3, 2017 / 5:12 PM / 7 months ago

BRIEF-GeNeuro provides update on GNbAC1 multiple sclerosis clinical program

1 Min Read

Jan 3 (Reuters) - GeNeuro SA :

* GeNeuro provides update on GNbAC1 multiple sclerosis clinical program

* Enrollment completed for CHANGE-MS study ahead of schedule; 6-month top-line results now expected in early 4Q2017

* U.S. study in secondary progressive MS patients planned for 2H 2017

* ANGEL-MS study launched, dosing of first patient expected in April 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below